Lyra Therapeutics, Inc.
Biotechnology · Healthcare
Chairman
2024-12-13–present
Maria Palasis, Ph.D.
Chairman
Lyra Therapeutics, Inc.
Equibles does not estimate personal net worth.
About Maria Palasis, Ph.D.
Maria Palasis, Ph.D. is recorded as Chairman at Lyra Therapeutics, Inc. since August 1, 2025. Lyra Therapeutics, Inc. reported in an 8-K filed August 1, 2025 that Maria Palasis, Ph.D. was appointed Chair of the Board, effective August 1, 2025. Lyra Therapeutics, Inc. reported in an 8-K filed December 13, 2024 that Maria Palasis, Ph.D. was appointed Class I Director, effective December 13, 2024. Lyra Therapeutics, Inc. reported in an 8-K filed December 13, 2024 that Maria Palasis, Ph.D. resigned as Class III Director, effective December 13, 2024. Lyra Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“The Board appointed Maria Palasis, Ph.D., the Company's President and Chief Executive Officer, as Chair of the Board, effective immediately.”
“on the same date, Dr. Palasis, who was a Class III Director, resigned as a director and was immediately elected by the Board as a Class I Director.”
Affiliation history
-
Lyra Therapeutics, Inc.
Chairman
SEC 8-K
Current2025-08-01–present
-
Lyra Therapeutics, Inc.
Board Member
SEC 8-K
2024-12-13–2024-12-13